DiviDrip · JAZZ

JAZZ — Jazz Pharmaceuticals plc

JAZZ is Jazz Pharmaceuticals plc (Healthcare) — a non-dividend-paying stock. Trading at $246.81. Market cap: $16.02B. Capital Quality Rank: 92/100 — Market alpha.

Stock snapshot

Price$246.81
Market cap$16.02B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)92 / 100 · Market alpha
ROIC (TTM)-4.7%
Revenue CAGR (3y)5.3%
Shareholder buyback yield8.24%
Altman Z-score zoneGrey

About JAZZ

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Listed2007Employees2.9KHQDublinSectorHealthcareWebsitejazzpharmaceuticals.com

Related non-dividend companies

Other non-dividend stocks investors research alongside JAZZ. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is JAZZ's current stock price?

JAZZ (Jazz Pharmaceuticals plc) is currently trading at $246.81.

Does JAZZ pay a dividend?

JAZZ (Jazz Pharmaceuticals plc) does not currently pay a regular dividend.

What is JAZZ's Capital Quality Rank?

JAZZ has a Capital Quality Rank of 92/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track JAZZ in DiviDrip

Add JAZZ to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow